End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.86 CNY | +0.62% | -3.33% | +51.14% |
05-13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
04-25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 2,524
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical and Healthcare
99.8
%
| 2,997 | 99.8 % | 3,304 | 99.8 % | +10.27% |
Others
0.2
%
| 5 | 0.2 % | 7 | 0.2 % | +35.23% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 3,002 | 100.0 % | 3,311 | 100.0 % | +10.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Peng Yu
DFI | Director of Finance/CFO | 55 | - |
Jia Shu Jiang
BRD | Director/Board Member | 51 | - |
Yan Chen
BRD | Director/Board Member | 52 | - |
Guo Xin Feng
BRD | Director/Board Member | 35 | - |
Zi Run Pan
BRD | Director/Board Member | 52 | - |
Xi Zhen Wu
BRD | Director/Board Member | 60 | 17/04/06 |
Gai Li Mao
IRC | Investor Relations Contact | - | - |
Qiang Ye
PRN | Corporate Officer/Principal | 52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Xi Zhen Wu
BRD | Director/Board Member | 60 | 17/04/06 |
Jun Yang
BRD | Director/Board Member | 55 | 17/05/23 |
Zi Run Pan
BRD | Director/Board Member | 52 | - |
Jin Li
CHM | Chairman | 59 | - |
Guo Xin Feng
BRD | Director/Board Member | 35 | - |
Yan Chen
BRD | Director/Board Member | 52 | - |
Hui Li
BRD | Director/Board Member | 57 | 04/06/20 |
Jia Shu Jiang
BRD | Director/Board Member | 51 | - |
Bao Dong Cheng
BRD | Director/Board Member | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 575,106,322 | 426,356,733 ( 74.14 %) | 7,966,080 ( 1.385 %) | 74.14 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
19,226,445 | 3.28% | 67,570,764 $ |
Company contact information
Henan Lingrui Pharmaceutical Co., Ltd.
666 Jiangjun Road Xin County
465550, Xinyang
+86 37 6298 8888
http://www.lingrui.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+51.14% | 2.02B | |
+44.36% | 6.34B | |
-13.52% | 4.61B | |
+10.85% | 3.39B | |
-6.52% | 3.29B | |
-0.71% | 2.58B | |
-5.22% | 1.73B | |
+1.29% | 1.67B | |
+57.69% | 1.63B | |
-9.67% | 1.59B |
- Stock Market
- Equities
- 600285 Stock
- Company Henan Lingrui Pharmaceutical Co., Ltd.